Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
The American Journal of Cardiology
|
November 9, 2010
Impact of clinical presentation and pretest likelihood on the relation between calcium score and computed tomographic coronary angiography
Jacob M van Werkhoven, Stephanie M de Boer, Joanne D Schuijf, et al.
The International Journal of Cardiovascular Imaging
|
May 12, 2012
Non-invasive computed tomography coronary angiography as a gatekeeper for invasive coronary angiography
Fleur R de Graaf, Joëlla E van Velzen, Stephanie M de Boer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial
Stephanie M de Boer, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 25, 2022
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
Lisa Vermij, Alicia Léon-Castillo, Naveena Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer
Nanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
The Lancet. Oncology
|
July 12, 2016
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
British Journal of Cancer
|
January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Clinical and Translational Radiation Oncology
|
February 12, 2026
Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy
Anouk Corbeau, Marij J P Welters, Sanne Boekestijn, et al.
Nature Communications
|
March 17, 2022
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
Nanda Horeweg, Hagma H Workel, Dominik Loiero, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
Merve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
The American Journal of Cardiology
|
November 9, 2010
Impact of clinical presentation and pretest likelihood on the relation between calcium score and computed tomographic coronary angiography
Jacob M van Werkhoven, Stephanie M de Boer, Joanne D Schuijf, et al.
The International Journal of Cardiovascular Imaging
|
May 12, 2012
Non-invasive computed tomography coronary angiography as a gatekeeper for invasive coronary angiography
Fleur R de Graaf, Joëlla E van Velzen, Stephanie M de Boer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial
Stephanie M de Boer, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 25, 2022
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
Lisa Vermij, Alicia Léon-Castillo, Naveena Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer
Nanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
The Lancet. Oncology
|
July 12, 2016
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, et al.
British Journal of Cancer
|
January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Clinical and Translational Radiation Oncology
|
February 12, 2026
Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy
Anouk Corbeau, Marij J P Welters, Sanne Boekestijn, et al.
Nature Communications
|
March 17, 2022
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
Nanda Horeweg, Hagma H Workel, Dominik Loiero, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
Merve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Page
of 4